CVE:ADK DIAGNOS (ADK) Stock Price, News & Analysis → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free ADK Stock Alerts C$0.30 -0.01 (-1.67%) (As of 04/24/2024 05:23 PM ET) Add Compare Share Share Today's RangeC$0.29▼C$0.3150-Day RangeC$0.24▼C$0.3552-Week RangeC$0.23▼C$0.59Volume45,500 shsAverage Volume85,912 shsMarket CapitalizationC$22.35 millionP/E RatioN/ADividend Yield0.29%Price TargetC$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider Trades Get DIAGNOS alerts: Email Address Ad Stansberry ResearchHow to camouflage a factory of 53,000 workers"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. About DIAGNOS Stock (CVE:ADK)DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Read More ADK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ADK Stock News HeadlinesFebruary 23, 2024 | ca.finance.yahoo.comGot $1,000? 2 Stocks to Buy Now While They’re on SaleFebruary 21, 2024 | finance.yahoo.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 9, 2024 | theglobeandmail.comClosing Bell: Diagnos Inc flat on Thursday (ADK)January 16, 2024 | msn.comDiagnos appoints Yves-Stéphane Couture as chief operating officerJanuary 16, 2024 | finance.yahoo.comDIAGNOS Appoints New Chief Operating OfficerDecember 8, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - ADKNovember 18, 2023 | finance.yahoo.comDIAGNOS Inc. (ADK.V)April 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.November 14, 2023 | msn.comThe last government shutdown deadline ousted the House speaker. This week's showdown could be easierNovember 4, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc flat on Friday (ADK)October 24, 2023 | investing.comDiagnos Laboratorium Utama PT Tbk (DGNS)October 7, 2023 | stockhouse.comDIAGNOS AI Retina Analysis is being deployed across Canada's Largest Specialist Care Provider in Diabetes & EndocrinologyOctober 5, 2023 | finance.yahoo.comDIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & EndocrinologySeptember 8, 2023 | baystreet.caDiagnos, Appulse, Bedford at 52-Week HighsJuly 15, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc down on Friday (ADK)July 6, 2023 | markets.businessinsider.comEchelon Wealth Partners Believes Diagnos (ADK) Won’t Stop HereMay 17, 2023 | finance.yahoo.comDIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”May 15, 2023 | baystreet.caTMX, Arrow, CPKC at 52-Week Highs on NewsMay 11, 2023 | usatoday.comMichael J. Fox: Do you have Parkinson's? New test is 'breakthrough' in diagnosing disease.May 4, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Wednesday (ADK)May 2, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Monday (ADK)April 28, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Thursday (ADK)April 19, 2023 | theglobeandmail.comClosing Bell: Diagnos Inc up on Tuesday (ADK)February 28, 2023 | finance.yahoo.comDIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of ContextsDecember 15, 2022 | finance.yahoo.comDIAGNOS Provides Additional Information to the Closing of Private PlacementNovember 6, 2022 | reuters.comADK.V - Diagnos Inc | Stock Price & Latest News | ReutersSee More Headlines Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today4/25/2024Next Earnings (Estimated)7/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ADK CUSIPN/A CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$1.50 High Stock Price TargetC$1.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+408.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-3,040,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-150.84% Debt Debt-to-Equity Ratio245.28 Current Ratio0.70 Quick Ratio0.68 Sales & Book Value Annual SalesC$577,486.00 Price / Sales38.71 Cash FlowC$0.00 per share Price / Cash Flow60.00 Book ValueC($0.04) per share Price / Book-7.38Miscellaneous Outstanding Shares75,770,000Free FloatN/AMarket CapC$22.35 million OptionableNot Optionable Beta-0.33 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Andre LarenteCEO, President & Executive ChairmanMr. Marc-André MassueVP of Finance, CFO & SecretaryMr. Yves-Stéphane CoutureChief Operating OfficerMr. Martin BelandDirector of MarketingKey CompetitorsCloudMD Software & ServicesCVE:DOCReliq Health TechnologiesCVE:RHTAurora SpineCVE:ASGLiberty BiopharmaCVE:LTYTrilogy International PartnersTSE:TRLView All CompetitorsInsidersTristram CoffinSold 800,000 sharesTotal: C$240,000.00 ($0.30/share)View All Insider Transactions ADK Stock Analysis - Frequently Asked Questions Should I buy or sell DIAGNOS stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DIAGNOS in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ADK shares. View ADK analyst ratings or view top-rated stocks. What is DIAGNOS's stock price target for 2024? 1 Wall Street research analysts have issued twelve-month price targets for DIAGNOS's stock. Their ADK share price targets range from C$1.50 to C$1.50. On average, they expect the company's stock price to reach C$1.50 in the next year. This suggests a possible upside of 408.5% from the stock's current price. View analysts price targets for ADK or view top-rated stocks among Wall Street analysts. How have ADK shares performed in 2024? DIAGNOS's stock was trading at C$0.41 at the beginning of 2024. Since then, ADK stock has decreased by 27.2% and is now trading at C$0.30. View the best growth stocks for 2024 here. When is DIAGNOS's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 11th 2024. View our ADK earnings forecast. How were DIAGNOS's earnings last quarter? DIAGNOS Inc. (CVE:ADK) posted its earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The business had revenue of $0.05 million for the quarter, compared to the consensus estimate of $0.10 million. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN). How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ADK) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
